These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5170812)

  • 1. Evidence for anti-leukocyte antibodies as a mechanism for drug-induced agranulocytosis.
    McIntyre PA; Laleli YR; Hodkinson BA; Wagner HN
    Trans Assoc Am Physicians; 1971; 84():217-28. PubMed ID: 5170812
    [No Abstract]   [Full Text] [Related]  

  • 2. White-cell antibodies and the aetiology of Felty's syndrome.
    Rosenthal FD; Beeley JM; Gelsthorpe K; Doughty RW
    Q J Med; 1974 Apr; 43(170):187-203. PubMed ID: 4546979
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis.
    Wiik A; Munthe E
    Immunology; 1974 Jun; 26(6):1127-34. PubMed ID: 4604253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune neutropenia.
    Logue GL
    Prog Clin Biol Res; 1984; 149():155-65. PubMed ID: 6739502
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell- and humoral-mediated granulopoietic failure detected by CFU-GM assay in one case of Felty's syndrome unresponsive to prednisolone treatment.
    Carlo Stella C; Ghizzi A; Bonfichi M; Pedrazzoli P; Bobbio Pallavicini E; Gorini M
    Haematologica; 1985; 70(4):296-302. PubMed ID: 3935526
    [No Abstract]   [Full Text] [Related]  

  • 6. Aprindine-induced agranulocytosis. Evidence for immunologic mechanism.
    Pisciotta AV; Cronkite C
    Arch Intern Med; 1983 Feb; 143(2):241-3. PubMed ID: 6401987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome.
    Starkebaum G; Singer JW; Arend WP
    Clin Exp Immunol; 1980 Feb; 39(2):307-14. PubMed ID: 7389203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in chemotaxix of polymorphonuclear leukocytes in patients with Felty's syndrome].
    Zivkovic M; Baum C
    Srp Arh Celok Lek; 1973 Oct; 101(10):771-5. PubMed ID: 4802923
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept in treatment of Felty's syndrome.
    Ghavami A; Genevay S; Fulpius T; Gabay C
    Ann Rheum Dis; 2005 Jul; 64(7):1090-1. PubMed ID: 15958767
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutrophil surface-bound immunoglobulin--a feature of Felty's syndrome?
    Minchinton RM; Doyle DV; Waters AH
    Clin Lab Haematol; 1982; 4(2):131-8. PubMed ID: 6749384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salazosulfapyridine-induced remission of Felty's syndrome along with significant reduction in neutrophil-bound immunoglobulin G.
    Ishikawa K; Tsukada Y; Tamura S; Kaneko Y; Kuroiwa T; Ueki K; Sugiura T; Nojima Y
    J Rheumatol; 2003 Feb; 30(2):404-6. PubMed ID: 12563703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
    Starkebaum G; Arend WP; Nardella FA; Gavin SE
    J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Felty's syndrome without splenomegaly. A case report (author's transl)].
    Gómez Casal F; Soler Mantilla H; Abós Olivares E; Fuertes Palacio MA; Asín de Hungría J
    Med Clin (Barc); 1981 Feb; 76(4):185-7. PubMed ID: 7206885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of leukocyte isoantibodies].
    Miura M; Hirano M
    Rinsho Byori; 1969 Mar; 17(3):219-24. PubMed ID: 5817180
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B; Ciaglo A; Schatz H; Coakley G
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felty's syndrome, pseudo-felty's syndrome, monoclonal or polyclonal CD3 lymphocytosis of undetermined significance.
    Masson C; Perroux-Goummy L; Audran M
    Rev Rhum Engl Ed; 1996 Jan; 63(1):5-8. PubMed ID: 9064110
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological mechanisms in drug-induced blood dyscrasias.
    Nydegger U; Miescher PA
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():46-9. PubMed ID: 783213
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune and toxic mechanisms in drug-induced agranulocytosis.
    Pisciotta AV
    Semin Hematol; 1973 Oct; 10(4):279-310. PubMed ID: 4139755
    [No Abstract]   [Full Text] [Related]  

  • 20. [Felty's syndrome].
    Jevtić Z; Benedeto L; Janković Z; Kocić D
    Reumatizam; 1971; 18(2):54-6. PubMed ID: 5209108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.